Keyphrases
Circulating Tumor DNA (ctDNA)
71%
Cell-free DNA (cfDNA)
37%
Advanced Lung Adenocarcinoma
31%
DNA Sequencing
31%
Liquid Biopsy
28%
Dutch
21%
Clinical Practice
19%
Molecular Profiling
19%
Molecular Tumor Profiling
19%
Analytical Workflow
18%
In Cancer
18%
Technical Assessment
15%
Cancer Patients
15%
CcfDNA
15%
Mutation Analysis
15%
DNA Extraction
15%
Downstream Analysis
15%
Early Treatment
15%
DNA Testing
15%
Immune Checkpoint Inhibitors
15%
Early Tumor Recurrence
15%
Expression Data
15%
Micro-costing
15%
Clinical Pathology
15%
External Quality Assessment
15%
Next-generation Sequencing
14%
Preanalytical Phase
14%
Diagnostic Leukapheresis
12%
Plasma Samples
11%
Commercially Available
11%
Sequencing Artifacts
7%
Apologizing
7%
Progressive Disease
7%
Following Error
7%
PD-L1 Expression
7%
Radiology Workflow
7%
Droplet Digital PCR (ddPCR)
6%
Clinical Implementation
6%
Routine Diagnostics
5%
Analysis Workflow
5%
DNA Analysis
5%
Extraction Methods
5%
Detection Rate
5%
Medicine and Dentistry
Circulating Tumor DNA
100%
Cell-Free DNA
69%
Neoplasm
64%
Non Small Cell Lung Cancer
31%
Clinical Pathology
31%
Liquid Biopsy
30%
Diagnosis
28%
Epidermal Growth Factor Receptor
27%
DNA Determination
21%
Malignant Neoplasm
21%
Next Generation Sequencing
20%
Molecular Profiling
19%
Pancreas Adenocarcinoma
15%
Mass Spectrum
15%
Tumor Recurrence
15%
Non-Small Cell Lung Cancer
15%
Immune Checkpoint Inhibitor
15%
Decision Making
14%
Leukapheresis
13%
Hazard Ratio
13%
Droplet Digital Polymerase Chain Reaction
13%
Venous Blood
9%
Hematopoiesis
9%
Specific Tumor
8%
Exon
7%
Overall Survival
7%
Polymerase Chain Reaction
6%
Gene Frequency
6%
Disease Exacerbation
6%
Biological Marker
5%
Biochemistry, Genetics and Molecular Biology
Circulating Tumor DNA
95%
Immune Checkpoints
31%
Epidermal Growth Factor Receptor
27%
DNA Analysis
21%
Hematopoiesis
17%
Decision Making
16%
Leukocyte
15%
DNA Extraction
15%
Mass Spectrometry
15%
PD-L1
15%
Droplet Digital Polymerase Chain Reaction
10%
Next Generation Sequencing
10%
Gene Frequency
9%
KRAS
9%
Exon
7%
Leukapheresis
7%
Germline
7%
Germ Cell
7%
Pre-Analytical Phase
5%
Sensitive Detection
5%
Magnetism
5%
